Sinotherapeutics Inc. (SHA:688247)
China flag China · Delayed Price · Currency is CNY
10.90
-0.03 (-0.27%)
At close: Jul 11, 2025, 2:57 PM CST

Sinotherapeutics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
148.96225.79641.79763.15511.66434.17
Upgrade
Short-Term Investments
--107.2144.09--
Upgrade
Trading Asset Securities
584.45507.74----
Upgrade
Cash & Short-Term Investments
733.41733.53749807.23511.66434.17
Upgrade
Cash Growth
-0.68%-2.07%-7.21%57.77%17.85%68.23%
Upgrade
Accounts Receivable
72.55110.9778.4771.2744.0935.84
Upgrade
Other Receivables
2.780.30.57--10.54
Upgrade
Receivables
75.32111.2779.0471.2744.0946.38
Upgrade
Inventory
102.4102.4284.6129.3840.4341.81
Upgrade
Other Current Assets
72.1629.139.3645.8322.6623.64
Upgrade
Total Current Assets
983.29976.32952.01953.71618.83546
Upgrade
Property, Plant & Equipment
356.91344.34271.41255.92115.09105.72
Upgrade
Long-Term Investments
64.4164.4264.249.169.997.86
Upgrade
Goodwill
18.3918.3918.3918.39--
Upgrade
Other Intangible Assets
19.9521.6527.5932.4741.1651.58
Upgrade
Long-Term Deferred Tax Assets
18.9619.3314.2916.4516.0814.44
Upgrade
Long-Term Deferred Charges
0.810.921.211.993.153.81
Upgrade
Other Long-Term Assets
5.947.9412.544.31.59.39
Upgrade
Total Assets
1,4691,4531,3621,332865.81738.8
Upgrade
Accounts Payable
27.6116.7513.348.428.015.39
Upgrade
Accrued Expenses
12.6826.4914.6911.5814.1932.15
Upgrade
Current Portion of Leases
0.010.010.060.320.78-
Upgrade
Current Income Taxes Payable
7.326.971.280.457.85-
Upgrade
Current Unearned Revenue
37.8230.4448.0156.846.7895.51
Upgrade
Other Current Liabilities
15.5922.5413.3312.4711.929.48
Upgrade
Total Current Liabilities
101.02103.1990.7290.0589.52142.54
Upgrade
Long-Term Leases
--0.021.23.66-
Upgrade
Long-Term Unearned Revenue
71.7974.7258.0961.1264.6230.93
Upgrade
Long-Term Deferred Tax Liabilities
2.362.392.532.682.822.96
Upgrade
Total Liabilities
175.17180.3151.36155.05160.62176.42
Upgrade
Common Stock
453.34453.34453.34453.34408408
Upgrade
Additional Paid-In Capital
513.57513.57512.89512.89179.23171.29
Upgrade
Retained Earnings
362.71342.22244.16211.19118.26-16.66
Upgrade
Treasury Stock
-36.13-36.13----
Upgrade
Comprehensive Income & Other
---0.13-0.15-0.31-0.26
Upgrade
Shareholders' Equity
1,2931,2731,2101,177705.19562.38
Upgrade
Total Liabilities & Equity
1,4691,4531,3621,332865.81738.8
Upgrade
Total Debt
0.010.010.091.524.44-
Upgrade
Net Cash (Debt)
733.4733.53748.92805.71507.22434.17
Upgrade
Net Cash Growth
-0.67%-2.05%-7.05%58.85%16.82%68.23%
Upgrade
Net Cash Per Share
1.651.611.591.911.241.06
Upgrade
Filing Date Shares Outstanding
449449449.15453.34408408
Upgrade
Total Common Shares Outstanding
449449453.34453.34408408
Upgrade
Working Capital
882.27873.13861.29863.66529.31403.47
Upgrade
Book Value Per Share
2.882.842.672.601.731.38
Upgrade
Tangible Book Value
1,2551,2331,1641,126664.02510.79
Upgrade
Tangible Book Value Per Share
2.802.752.572.481.631.25
Upgrade
Buildings
-216.23211.6854.2952.4145.57
Upgrade
Machinery
-183.49160.89145.6135.93117.73
Upgrade
Construction In Progress
-80.7515.35153.614.689.32
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.